In liver hepatocellular carcinoma and lung adenocarcinoma, CXCL2 and PPBP negatively correlated with proliferation, and were the only CXCR2 ligands that negatively correlated with the count of MDSCs. Here, CXCR2 is linked to lung adenocarcinoma.